THERALASE
LIVE

Serial Number

97343587

Owner

Theralase Technologies Inc.

Attorney

David M. Tener, Esq.

Filing Date

Apr 1, 2022

Add to watchlist:

No watchlists yet
View on USPTO

THERALASE Trademark

Serial Number: 97343587

THERALASE is a trademark filed by Theralase Technologies Inc. on April 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Theralase Technologies Inc. (9 trademarks)

41 Hollinger Road
Toronto, ON M4B 3G4 , CA

Entity Type: 03

Trademark Details

Filing Date

April 1, 2022

Registration Date

Not Registered

Goods & Services

Anti-cancer preparations; tumor suppressing agents; photosensitizing agents for photodynamic therapy, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, compounds in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill pathogens; disinfectant compositions activatable by light and/or ionizing radiation to kill pathogens; photosensitizing compositions in the nature of therapeutic agents activatable by light and/or ionizing radiation to kill tumor cells

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 8, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 8, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 8, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 8, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 15, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 15, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 15, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 24, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 23, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 23, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jun 23, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 3, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 19, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 19, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 19, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 24, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 17, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 17, 2024 GNSL
SUSPENSION LETTER WRITTEN
Apr 17, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2024 CRFA
ASSIGNED TO LIE
Apr 17, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 28, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 29, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 29, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 29, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 8, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 24, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 24, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jan 24, 2023 CNSL
ASSIGNED TO EXAMINER
Jan 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2022 NWOS
NEW APPLICATION ENTERED
Apr 5, 2022 NWAP